The Pennant Group (NASDAQ:PNTG - Get Free Report) is expected to issue its Q1 2025 quarterly earnings data after the market closes on Tuesday, May 6th. Analysts expect the company to announce earnings of $0.22 per share and revenue of $201.40 million for the quarter.
The Pennant Group Trading Down 0.1 %
Shares of PNTG stock opened at $25.55 on Tuesday. The Pennant Group has a 1 year low of $20.23 and a 1 year high of $37.13. The firm has a fifty day moving average price of $24.62 and a 200-day moving average price of $27.80. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.12 and a quick ratio of 1.12. The company has a market cap of $887.15 million, a price-to-earnings ratio of 37.57, a PEG ratio of 2.24 and a beta of 1.73.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the stock. Truist Financial cut their price objective on shares of The Pennant Group from $32.00 to $28.00 and set a "hold" rating for the company in a research report on Friday, March 7th. Stephens reissued an "overweight" rating and set a $38.00 price target on shares of The Pennant Group in a report on Wednesday, April 2nd. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $34.80.
Read Our Latest Report on The Pennant Group
The Pennant Group Company Profile
(
Get Free Report)
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider The Pennant Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.
While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
